summary report 1.16.19 (6) trust board...aspiration pneumonitis; food/vomitus 120 35.31 34 17.60%...
TRANSCRIPT
SUMMARY REPORT 1.16.19 (6)
TRUST BOARD 25th February 2016
Subject Mortality Report
Prepared by Frances Keane, Deputy Medical Director
Approved by Dr Rob Parry, Medical Director
Presented by Dr Rob Parry, Medical Director
Purpose
To update the Board concerning current mortality statistics and provide an overview of the actions presently being undertaken in response to Trust wide position. This paper updates the Board on: Mortality statistics The Trust Mortality Committee work plan and improvement
agenda The Sepsis Steering Group work plan and improvement
agenda The work plan relating to Deteriorating Patient agenda
Receive ●
Approve
Trust Objectives
Quality People Partnership Resources
● ●
Executive Summary
Our mortality indicator continues to be a major concern for the Trust (HMSR 114.71, baseline 100) and we continue to address this as a priority. The latest 12 month rolling HSMR is: 114.71 (December 2014 – November 2015). The excess deaths are mainly in medicine apart from Fractured Neck of Femur. The alerts for the period December 2014 – November 2015 were 6 alerting diagnosis groups:-
Acute cerebrovascular disease Chronic renal failure Fluid and electrolyte disorders Fracture neck of femur (hip) Septicaemia Urinary tract infections
Key Mortality improvement actions. Mortality improvement actions:
Mortality 1. Review of Mortality action plan- to define key areas of improvement
Page 2 of 2
2. On-going review of weekend nurse cover ( in line with junior doctor and Consultant cover)
3. Mortality awareness shared conversation sessions (x3 ) led by Deputy MD Sepsis
4. Weekly ED Sepsis grand round attended by ED Consultant, Chair Sepsis Steering Group, Deputy MD, Consultant Nurse-ED, ANP, Associate Director Clinical Governance, Ward Sister
5. Purchase of 3 Sepsis trollies for ED & MAU 6. Daily sepsis audits in ED/MAU
Paediatric Sepsis
7. New observation charts incorporating PEW scores and actions to assess against PEW>2 introduced end 2015
8. Sepsis stickers to guide sepsis six with audit tool for completed stickers. 9. New paediatric patient flow management system implementation date Feb 2016 with
automated request for review if PEW >2 (electronic whiteboard). Education
10. Review of sepsis half day training programme- to a shorter 2 hour session that all ED & MAU staff must attend ( must do)
11. Online sepsis education programme for all staff ( must do) 12. Deteriorating patient education change programme for all staff ( must do) with an aim
to roll out the change package following the same ward list programme as the E-obs scheduling but over 30, 60, 90 day timescale.
13. Launch event for the Ward Sisters and Matrons at the start of each phase of the deteriorating patient education so that they are familiar with the change package.
14. Engage specialist/non ward based nurses in helping with the roll out of the deteriorating patient change education plan
Key Recommendations
For the Trust Board to note and receive the current report.
Assurance Framework
The report provides information on the key risks and current level of assurance in meeting the Trust’s objectives.
Next Steps
The Trust Board to receive regular reports to meeting and be kept informed by exception reporting outside of the meeting cycle as required.
Corporate Impact Assessment
CQC Regulations Covers all CQC regulations
Financial Implications None.
Legal Implications None.
Equality & Diversity None.
Workforce and Staffing
Performance Management None.
Communication None.
Acronyms / Terms used in Report
DFU Dr Foster Unit
CUSUM Cumulative sum chart
CIU Chemotherapy Intelligence Unit
1
Royal Cornwall Hospitals NHS Trust – Mortality Data
1. DECEMBER 2014 – NOVEMBER 2015 (Information downloaded from HED on 8 February 2016) 1.1 Mortality Update Mortality is a key indicator of the trusts safety and effectiveness; this can be expressed in 2 ways, HSMR and SHMI. HSMR is a metric that looks at 56 key diagnoses for in hospital deaths, these 56 diagnoses make 80-90% of the Trusts deaths. SHMI looks at all deaths in hospital regardless of diagnosis, plus all deaths for patients who died in the 30 days following discharge from hospital, this does not adjust for patients who were discharged from hospital with palliative care support in their own home or a hospice, nor is there a requirement for the patient’s death to be related to their previous hospital admission. HSMR and SHMI are both measures of quality of care that use patient records to determine a patients mortality risk based on a number of factors including age, gender, diagnosis, comorbidities and background and lifestyle factors. Outcomes are then compared to this risk and when expressed for the entire Trust are expressed as a number; 100 is considered to be average with anything below 100 showing more patients who would have been expected to die survived (i.e. excellent care) whilst above 100 shows some patients died that may have been expected to survive (potential improvements in care required). 1.2 Trust position- December 2014 – November 2015 HSMR = 114.71 (December 2014 – November 2015) / 114.98 (November 2015)
Flagging for the year as lower confidence interval (LCI) is more than 100, currently at 109.21
Not flagging for November 2015 as LCI is 96.91 Total number of deaths = 1626 (12 months) / 143 (November 2015)
2
Table 1: HSMR Funnel Plot: December 2014 – November 2015
Non-elective non-weekend admissions have alerted for the 12 months ending November 2015:
HSMR = 111.77 LCI = 105.53
Non-elective weekend admissions have alerted for the 12 months ending November 2015:
HSMR = 123.78 LCI = 112.36
3
Table 2: Rolling 12 Month HSMR: December 2014 – November 2015
4
1.3 6 diagnostic groups alerting (lower confidence interval >100):
Acute cerebrovascular disease Chronic renal failure
HSMR = 121.73 HSMR = 114.71
Fluid & electrolyte disorders HSMR = 187.24 Fracture neck of femur (hip) HSMR = 143.4 Septicaemia Urinary tract infections
HSMR = 128.75 HSMR = 146.65
Table 3: HED HSMR Diagnostic Group Dashboard: December 2014 – November 2015
CCS Diagnostic Group
Nu
mb
er o
f D
isch
arg
es
Exp
ecte
d
nu
mb
er
of
dea
ths
Nu
mb
er o
f d
eath
s
% o
f d
eath
s at
trib
ute
dth
rou
gh
tra
nsf
er
HS
MR
HS
MR
95%
Lo
wer
CI
HS
MR
95%
Up
per
CI
HS
MR
(w
ith
ou
tad
just
ing
fo
r p
allia
tive
care
)
Nu
mb
er
of
pal
liati
ved
isch
arg
es
Ave
rag
e C
om
orb
idit
ies
per
Sp
ell
Mo
rtal
ity
Rat
e
Abdominal pain 2231 4.29 7 14.30% 163.14 65.36 336.14 167.39 6 1.9 0.31% Acute and unspecified renal failure 367 51.37 63 17.50% 122.64 94.23 156.91 122.79 24 14.88 17.17% Acute bronchitis 821 10.66 11 0.00% 103.2 51.45 184.67 105.35 8 2.73 1.34% Acute cerebrovascular disease 791 128.16 156 16.00% 121.73 103.37 142.4 113.53 17 10.48 19.72% Acute myocardial infarction 712 64.32 56 10.70% 87.06 65.76 113.06 89.75 12 9.16 7.87% Aortic; peripheral; and visceral artery aneurysms 128 16.99 18 11.10% 105.95 62.76 167.45 111.66 4 6.2 14.06% Aspiration pneumonitis; food/vomitus 120 35.31 34 17.60% 96.29 66.67 134.56 94.68 11 11.39 28.33% Biliary tract disease 1244 13.32 21 4.80% 157.64 97.54 240.98 150.23 7 2.96 1.69% Cancer of bladder 1136 4.96 7 14.30% 141.12 56.54 290.77 118.91 6 3.89 0.62% Cancer of breast 2181 6.48 6 16.70% 92.54 33.79 201.43 104.57 11 9.24 0.28% Cancer of bronchus; lung 1050 33.24 33 21.20% 99.29 68.34 139.45 104.79 53 10.77 3.14% Cancer of colon 968 12.73 15 26.70% 117.82 65.9 194.34 119.28 17 12.04 1.55% Cancer of esophagus 357 9.69 8 12.50% 82.58 35.56 162.73 87.54 16 7.95 2.24% Cancer of ovary 504 6.42 6 0.00% 93.49 34.14 203.5 125.99 16 11.34 1.19%
5
Cancer of pancreas 272 11.4 16 6.30% 140.39 80.19 228 146.67 24 11.44 5.88% Cancer of prostate 818 8.24 6 0.00% 72.77 26.57 158.4 78.77 14 8.86 0.73% Cancer of rectum and anus 588 6.19 5 0.00% 80.8 26.04 188.57 76.6 9 10.02 0.85% Cancer of stomach 167 2.55 2 0.00% 78.48 8.81 283.34 79.3 4 13.64 1.20% Cardiac arrest and ventricular fibrillation 63 35.71 39 0.00% 109.22 77.66 149.31 110.89 5 11.79 61.90% Cardiac dysrhythmias 1270 13.96 15 13.30% 107.42 60.08 177.19 116.87 6 6.52 1.18% Chronic obstructive pulmonary disease and bronchie 868 37.47 49 10.20% 130.77 96.74 172.89 121.57 13 6.24 5.65% Chronic renal failure 665 3.32 8 50.00% 240.85 103.7 474.59 267.83 5 1.63 1.20% Chronic ulcer of skin 98 5.98 11 36.40% 184.01 91.73 329.26 207.87 3 10.54 11.22% Complication of device; implant or graft 1163 8.6 11 27.30% 127.94 63.78 228.93 118.38 6 4.6 0.95% Congestive heart failure; nonhypertensive 660 70.06 87 12.60% 124.19 99.47 153.19 119.24 19 8.8 13.18% Coronary atherosclerosis and other heart disease 1894 12.67 12 8.30% 94.72 48.89 165.47 92.86 2 6.89 0.63% Deficiency and other anaemia 1800 3.78 8 12.50% 211.82 91.21 417.39 198.16 4 6.22 0.44% Fluid and electrolyte disorders 227 10.68 20 25.00% 187.24 114.32 289.19 189.58 8 10.27 8.81% Fracture of neck of femur (hip) 677 50.91 73 28.80% 143.4 112.4 180.31 140.39 11 10.32 10.78% Gastrointestinal haemorrhage 1031 38.11 47 10.60% 123.34 90.61 164.01 115.64 13 5.63 4.56% Intestinal obstruction without hernia 257 13.61 15 0.00% 110.22 61.64 181.8 104.9 8 4.35 5.84% Intracranial injury 169 21.05 27 7.40% 128.28 84.51 186.64 124.25 5 5.76 15.98% Leukaemia 1692 5.95 6 16.70% 100.85 36.83 219.51 96.94 12 1.57 0.35% Liver disease; alcohol-related 274 16.56 13 0.00% 78.52 41.77 134.28 75.57 3 6.26 4.74% Malignant neoplasm without specification of site 217 7.92 7 0.00% 88.43 35.43 182.2 77.88 9 13.32 3.23% Non-Hodgkin`s lymphoma 935 5.67 8 25.00% 141.04 60.73 277.92 163.89 8 2.13 0.86% Non-infectious gastroenteritis 497 1.2 1 0.00% 83.55 1.09 464.87 131.83 4 1.84 0.20% Other circulatory disease 398 4.2 2 0.00% 47.57 5.34 171.74 49.68 3 6.14 0.50% Other fractures 386 13.4 13 69.20% 97.01 51.6 165.9 98.02 5 5.83 3.37% Other gastrointestinal disorders 1989 13.19 15 6.70% 113.74 63.61 187.6 121.21 12 2.21 0.75% Other liver diseases 292 11.53 13 30.80% 112.72 59.96 192.76 127.16 8 10.51 4.45% Other lower respiratory disease 237 8.59 9 11.10% 104.72 47.79 198.81 107.58 5 4.59 3.80% Other perinatal conditions 929 14.09 14 0.00% 99.36 54.27 166.71 98.98 0 0 1.51% Other upper respiratory disease 839 4.75 6 66.70% 126.4 46.16 275.13 115.71 1 4.03 0.72% Peripheral and visceral atherosclerosis 206 25.93 22 9.10% 84.83 53.14 128.44 85.34 9 7.87 10.68% Peritonitis and intestinal abscess 35 6.94 7 28.60% 100.91 40.43 207.93 105.8 4 10.51 20.00% Pleurisy; pneumothorax; pulmonary collapse 295 10.53 14 14.30% 132.99 72.65 223.16 131.2 10 6.36 4.75% Pneumonia (except that caused by tuberculosis 2046 313.16 324 8.60% 103.46 92.5 115.37 99.33 74 10.43 15.84%
6
or s Pulmonary heart disease 236 14.28 17 29.40% 119.02 69.29 190.58 125.52 14 7.5 7.20% Respiratory failure; insufficiency; arrest (adult) 72 18.06 20 0.00% 110.77 67.63 171.08 103.87 2 12.61 27.78% Secondary malignancies 2339 26.34 26 34.60% 98.72 64.47 144.66 107.94 76 9.5 1.11% Senility and organic mental disorders 243 15.61 20 20.00% 128.16 78.25 197.95 123.46 7 11.68 8.23% Septicaemia (except in labor) 317 58.25 75 2.70% 128.75 101.26 161.39 126.44 22 12.5 23.66% Skin and subcutaneous tissue infections 853 11.23 15 6.70% 133.59 74.72 220.36 127.96 4 4.45 1.76% Syncope 632 4.67 9 33.30% 192.58 87.88 365.6 224.31 3 6.62 1.42% Urinary tract infections 1572 53.19 78 28.20% 146.65 115.92 183.03 150.2 30 7.5 4.96% Grand total 42828 1417.4 1626 14.30% 114.71 109.21 120.43 113 692 6.53 3.80%
7
1.4 Summary Hospital-level Mortality Indicator (SHMI) The data below shows the current quarterly SHMI for the period April 2014 – March 2015 SHMI = 107.13; LCI = 102.8 Table 4: Funnel Plot – RCHT benchmarked against all other Trusts
Table 5: Line Graph – RCHT
8
1.5 Trust Crude Mortality Rate
Crude Mortality Rate (per 1,000) based on all inpatient activity & deaths occurring in RCHT in a 12 month period (Includes elective & non-elective admissions; does not include ED admissions or ED deaths) (Compiled by Information Services 11 January 2016) Table 6: Trust Crude Mortality Rate: December 2014 – December 2015
Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15
9
1.6 Alerts This Month
For the period December 2014 – November 2015 there were 6 alerting diagnosis groups (flagging at a lower confidence interval (LCI) at >100):
Acute cerebrovascular disease Chronic renal failure Fluid and electrolyte disorders Fracture neck of femur (hip) Septicaemia Urinary tract infections
1.7 Standard & High Risk Tracking (HSMR & Alerts) The diagnosis groups below represent those as on-going high risk/high volume. The data highlighted in red captures those diagnoses with a lower confidence interval (LCI) at >100 (as captured in the HED diagnostic extracts) across the 12 month period. Table 7: Standard & High Risk Tracking (HSMR & Alerts)
*Already subject of previous in-depth review by CQC and TDA (#NoF as part of procedure group, Reduction of Bone)
1.8 Key Mortality improvement actions.
December 2014 – November 2015
November 2015
Diagnosis HSMR LCI No. of Deaths
Expected Deaths
HSMR LCI No. of Deaths
Expected Deaths
Pneumonia 103.46 92.5 324 313.16 98.53 63.11 24 24.36
Stroke 121.73 103.37 156 128.16 131.91 73.77 15 11.37
Congestive Heart Failure
124.19 99.47 87 70.06 111.82 48.15 8 7.15
Acute MI 87.06 65.76 56 64.32 128.11 46.78 6 4.68
Fracture NoF 143.4 112.4 73 50.91 152.42 49.12 5 3.28
Syncope 192.58 87.88 9 4.67 362.25 4.73 1 0.28
Chronic Renal Failure
240.85 103.7 8 3.32 607.02 7.93 1 0.16
Septicaemia 128.75 101.26 75 58.25 114.06 41.65 6 5.26
Weekend 123.78 112.36 430 347.39 141.97 104.67 48 33.81
Non-Weekend 111.77 105.53 1196 1070.04 104.90 84.87 95 90.56
A summary of the latest mortality data for the 12 month period December 2014 – November 2015, including: a snapshot of hospital activity during November 2015, monitoring of weekend/weekday mortality & previously
alerting and high risk diagnosis groups. (Healthcare Evaluation Data (HED) replaces Dr Foster from 1 July 2015)
10
The Mortality Improvement Plan has been reviewed for impact, with three areas identified for current focus as likely to have the greatest impact on morality reduction: sepsis recognition and management; the deteriorating patient; treatment escalation plans.
1.8.1 Sepsis recognition and management
Daily sepsis audits are being undertaken in the Emergency Department/Medical Admission Unit with feedback to staff. A weekly audit report is generated from the data collected by the Lead Nurse for Sepsis. The Lead Nurse for Sepsis follows this review with feedback to all ED staff on a weekly basis. No data comes from the MAU as all the patients have been originally admitted via the ED. The reason the hospital’s RADAR surveillance notes these patients in MAU is because they continue to NEWS at Red/Amber status once admitted.
A sepsis ‘Grand Round’ has been introduced in the Emergency Department. The ‘Grand Round’ is a weekly review meeting that includes the Emergency Department Consultant, Chair Sepsis Steering Group, Deputy Medical Director, Consultant Nurse Emergency Department, Advanced Nurse Practitioner Emergency Department, Associate Director Clinical Governance and the Lead Sepsis Nurse.
Three ‘sepsis’ trolleys are being purchased for the Emergency Department; the effective use of these will be audited for consideration of roll out to other areas.
Medical and Nursing staff in the Emergency Department are receiving a 15 minute highlight session each morning on being sepsis aware. All staff for the day shift assembles for handover in the ED staffroom. It is via this forum that the Lead Nurse for Sepsis joins them every morning to deliver a Sepsis safety briefing and remind all staff to screen for sepsis, and promptly report it to a Dr where they do identify sepsis. The Lead Nurse for Sepsis also provides verbal feedback based on the previous 24 hours’ worth of medical notes that she has checked for sepsis screening. There have been 5 briefing since this commenced on Thursday 11th February.
The Emergency Department Consultant has ensured that Junior Doctors are conversant with the plan for Sepsis hour to hour screening and prescribing.
The sepsis half day training programme has been reviewed with all Emergency Department and Medical Admission Unit staff to undertake the training over the next 90-120 days.
An online sepsis awareness video has been identified for use and is currently being made available to staff via the intranet.
Sepsis stickers have been introduced in paediatrics with an audit tool for completed stickers.
1.8.2 Recognising the deteriorating patient
A new observation chart for children has been introduced. This incorporates a paediatric early warning score and associated actions.
A new paediatric patient flow management system being implemented in 2016 has an automated request for review where the early warning score flags.
11
Electronic observation system has been successfully introduced on Grenville Ward. The roll out programme will implement in four additional wards weekly with full introduction due to complete October 2016
A deteriorating patient educational change package has been designed by the clinical training team. This will be rolled out alongside the electronic observation system using a 30, 60, 90 day phased programme. The change package will be introduced through a launch event at the start of each phase, with support for implementation being sourced from specialist nursing teams.
The critical care outreach team has been extended to cover 24 hours over the weekend for a one month evaluation period.
1.8.3 Treatment Escalation Plans
Medical Admission Unit has been identified as the focus area for improving use of Treatment Escalation Plans (TEPs).
An improvement programme, supported by the Palliative Care Specialist Nurses, is being finalised, with implementation to commence by end of February 2016.
Three open staff sessions have been scheduled during February 2016 to raise awareness amongst medical and nursing staff of the key mortality actions and to listen to staff’s views on what other actions are needed within the mortality plan for greatest impact.
An analysis of Trust and community deaths is being undertaken with the support of the Academic Health Science Network. This is due by the 26th February 2016.
2. Recommendation
The Trust Board are asked to note and receive the current report.
Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Mar-16
1.1 106.49 108.9 109.53 109.77 109.96 109.91 110.87 112.55 112.69 111.98 113.17 <100
1.2 Weekday 106.04 108.21 109.44 109.86 108.8 108.79 109.08 110.32 110.36 109.21 110.61 <1001.3 107.85 110.98 109.8 109.47 113.58 113.41 116.48 119.39 119.88 120.61 121.13 <100
2.1 9 Not available 13 14 Not available 7 3 6 7 8 5
2.2.1 Sepsisno flag Not available no flag no flag Not available no flag no flag no flag no flag 131.25 132.85 <100
2.2.2Redutction of fracture of bone (upper/lower limb) 170.13 Not available 194.25 142.98 Not available no flag
128.94(#NoF) 228.23 no flag
134.79 (#NoF)
140.19(#NoF) <100
SIs related to the deteriorating patient 3 4 4 3 1 0 0 1 0 0 1 0 0 1612 9 8 15 10 16 7 12 10 11 10 13 17 year total 120
Peri Arrests 11 15 18 5 8 7 7 9 8 10 4 13 8
5 Antibiotics within 1 hour for severe sepsis 61.5% (16/26)* Not available Not available 58% (15/26) 60% (28/47) 73% 37% 90%
121.14
175.52
140.19
132.85
152.95
HSMR alerts: October 2015
Fluid and electrolyte disorders
Fracture neck of femur (hip)
Septicaemia
Acute cerebrovavascular disease
Urinary tract infections
1
34
2
High Level KPIs Supporting the Mortality Improvement Plan
Version 1 - 17 March 2015, updated January 2016
Overall
WeekendHSMR
Cardiac Arrest Calls
Number of Mortality Alerts
Cardiac Arrests
Mortality Alerts:Observed / Expected
number of deaths2.2 CQC
Ser No
1
2
3
Key Performance Indicators and performance trajectory
Current 3 months 6 months 9 months
1 Quality 114.71 <100
2 Quality 111.77 <100
3 Quality 123.78 <100
4 Quality 5 25% reduction
5 Quality 120 10% reduction
6 Quality 85 10% reduction
7 Quality 62.0% 60.0%
8 Quality 44.0% 45.0% 51.0% 57.0% 64.0%
9 Quality 2 0 0 0 0
Key Issues/Risks to Delivery
Risk ID Likelihood Consequence Risk score Residual LikelihoodResidual
Consequence
Residual Risk
ScoreOwner Open/ Closed
5230
4 5 20 3 5 15Medical
DirectorOpen
Deliverables and Milestones
Ser No Key Area Target Date Accountable Action StatusDate
Completed
1 Infrastructure
31/01/2016‐
achieved
February 2016
Frazer
UnderwoodGreen
01/02/2016‐
Complete
2 Infrastructure 14‐Mar‐16
Frazer
Underwood/Jona
than Paddle
Amber 21‐Mar‐16
3 Infrastructure 29‐Feb‐16
Sheena
Wallace/Jonatha
n Paddle
Amber 17/02/2016
4 Infrastructure 29‐Feb‐16
Duncan
Bliss/Jonathan
Paddle
Amber 17‐Feb‐16
Additional coders appointed to review co‐morbidity coding in 6 frailty conditions Review of co‐morbidities in 6 fraility conditions to commence
Level 1 beds are required for patients needing a greater level of nursing care and monitoring support than that
provided through normal ward care. MAU
MORTALITY IMPROVEMENT PLAN ‐ MONTHLY STATUS REPORTPLAN STATUS
AMBER
Board/Executive Committee Trust Management Committee Plan updated by
Executive Lead Rob Parry Version 10
Local Monitoring Group/CommitteeMortality Review Committee/ Emergency
Care BoardDate Updated 11‐Feb‐16
Plan Objectives % Competition
Reduction in HSMR to <100 within 12 months (weekend and weekday)
25% reduction in serious incidents relating to suboptimal management of the deteriorating patient
Level 1 beds are required for patients needing a greater level of nursing care and monitoring support than that
provided through normal ward . Surgery ‐
Following an internal review by the Associate
Medical Director‐ ITU the Trust require an
agreement at the emergency care board (ECB)
of the need for additional level 1 beds on both
medicine and surgery. Options still being
discussed but no formal proposal in place‐
require a full and detailed update as to the
position of the increase in resources‐ to be
discussed at the February Emergency Care Board
Reduced cancellations of elective patients
requiring HDU post operatively following start
date.
Following an internal review by the Associate
Medical Director‐ ITU the Trust require an
agreement at the emergency care board (ECB)
of the need for additional level 1 beds on both
medicine and surgery. Options still being
discussed but no formal proposal in place‐
require a full and detailed update as to the
position of the increase in resources‐ to be
discussed at the February Emergency Care Board
Patients cared for in a safe environment by
appropriately skilled staff which should result in a
reduction in SI's
Review of HED flaggers ‐AKI, decubitus ulcers and weekend mortality due 31/01/16
Nerve‐centre (e‐Obs) phased roll out ude to commence Grenville ward 26/01/16 Revised mortality review process to commence
Description
Revised mortality review process discussed at MRC 20/01/16
National Hospital Standardised Mortality Ratio (HSMR)
data
indicates that the Trust has higher than average mortality,
particularly at weekends, leading to;
� Concerns about the quality and safety of clinical care.
� Trust reputation.
� Increased likelihood of regulatory intervention.
Mitigation
Awaiting meetingThe Trust is able to implement best practice from
a centre with established e‐obs use
10% reduction in cardiac arrest calls
HSMR Weekend rolling 12 month Trajectory and target for review 1 Feb 16
Physio cover for Trauma patietns delayed to Apr 16
Commentary
HSMR Overall rolling 12 month Trajectory and target for review 1 Feb 16
Sepsis 6 pathway compliance
Ser No
SIs related to the deteriorating patient ‐ 21 in 14/15
CQC open alerts Green 0, Amber 1‐2, Red 3 and above
MetricIncremental improvement trajectoryCurrent
PerformanceData Source
HSMR Weekday rolling 12 month Trajectory and target for review 1 Feb 16
Cardiac arrest calls ‐ Peri Arrests ‐ 108 in 14/15 Trajectory and target for review 1 Feb 16
Cardiac arrest calls ‐ cardiac arrest ‐ 133 in 14/15 Trajectory and target for review 1 Feb 16
Antibiotics within 1 hour for severe sepsis Trajectory and target for review 1 Feb 16
Trajectory and target for review 1 Feb 16
Revised care bundle stickers for COP pneumonia and chest pain launched Relaunch of cardiology care bundles‐ chest pain and heart failure
Teaching sessions for F1/F2 doctors delivered re respiratory care bundles Teaching sessions for F1/F2 doctors to support above
Tasks delayed in month (with revised completion) Decisions / Support required
orthogeriatrician not likey to be in place by Apr 16
Activities completed in month
Junior medical staff on Trauma will not be in place until August rotation Senior medical team support for coding review ‐finance identified,
business plan for level 1 beds in surgery Business cases/proposals from Medicine and Surgery for level 1 bed long‐term resourcing and respiratory consultant resource
Actions planned for next month
business plan for additional respiratory consultant resource Funding of Critical care outreach to include 24/7 at weekends as an initial step
business plan for level 1 beds in medicine
Action Progress / update Evidence /Outcome
E‐alerts : Assessment of eObservations functionality and
initial roll‐out to improve the recording, awareness and real‐
time reporting of the deteriorating patient
Infrastructure and messaging testing underway.
Adult NEWS specification signed off and with
nervecentre for system build. User acceptance
testing to commence second week of January
2016 with an anticipated go‐live date on launch
ward ‐Grenville. Launch date set for Grenville
February 16 .
Reduction of Sis expected relating to the
deteriorating patient. Impact expected after start
date
Visit planned to Nottingham to learn from thier introduction
of Nerve Centre and supporting Recognition and Rescue
initiatives 14/03/16
5a Infrastructure 31‐May‐16 Frances Keane Green 14/05/2016
6 Infrastructure 29‐Feb‐16
Paul
Johnson/Steve
Creely/Steve
Dickinson
Green 29/02/2016
7 Staffing 31‐Mar‐16 Sheena Wallace Amber 29‐Feb‐16
8
Staffing
31‐Mar‐16
Jonathan
Paddle/Duncan
Bliss
Amber
9Pathways and
protocols30‐Jun‐16 Michael Spivey Amber 30/06/2016
10Pathways and
protocols30‐Jun‐16
David Ashton‐
ClearlyGreen 31/07/2016
11Pathways and
protocols31‐Mar‐16
David Ashton‐
ClearlyGreen 31/03/2016
12Pathways and
protocols29‐Feb‐16 Jay Over Amber 30/06/2016
13Pathways and
protocols29‐Feb‐16
Kenna Duston/
Steve IlesGreen
Audit programme to be established to evidence
conformance
Increase in Senior Medical Cover: Increase endocrine/neuro and respiratory substantive capacity to
ensure consistent medical cover at weekends for enhanced
patient review
Review of co‐morbility coding of six frailty conditions
Additional coders have been appointed and
Senior Medical staff identified to assist with
verification and sign‐off ‐ completed. Work to
commenced 01 Feb 16‐ in hand.
Enhanced co‐morbility codings in six fraility
conditions
Data quality : Review of conditions flagging as outliers
on HED mortality data to ensure a standardised systematic approach to outliers and establish failures in
care requiring improvement
Review of weekend deaths (ie patients who are
admitted at the weekend and subsequently die)
and Acute Kidney Injury completed. Review of
decubitus ulcers underway
Reduction in deaths in conditions flagging as
outliers
Improved Consultant to consultant referral for in‐
patients. Implement an electronic referral system for in‐
patients only to enable more timely consultant to
consultant referrals.
62 specialties are now live with Maxims, 7
specialities still to go live.
Project handed over to IT support as Business as
Usual.
Internal Referral module modified to support the
Add to Waiting List and Pre‐operative
Assessment (POA) workflow, reducing the
waiting time for POA appointment by up to 4
weeks.
Internal Referral module modified to support
clinical test and procedure requests.
Audit on delayed reviews to enable urgent
patients to be seen on the day of referral ‐ report
due on 7 Jan 16 ‐ KD will then inform Service Leads
and Clinical Leads and supports it's use. Audit
report data items agreed with Information
Services. Under development, and will be
available on Radar in a couple of weeks for users.
KD to send comms as soon as it is available.
Some improvement in recognition of sepsis
noted (NEWS completion 73% 01/16 c/t 36%
09/15) and deliverly of iv antibiotics 62% 01/16
c/t 50% 09/15) observed but needs
strengthening. Revised training programme,
including on‐line resource and shorter simulation
planned, weekly ED sepsis round introduced with
input from sepsis lead and key ED staff, Sepsis
trolley being trialled in ED, daily sepsis high‐
lighting to all staff, Paediatric screening tool
(PEWS) introduced.
Re‐launch of Key Care Bundles : phase 2: Chest pain
and heart failure
Programmes for training of F1/2 doctors in chest
pain and LVF in place for Dec 2015 & Jan 2016.
Revised chest pain care bundle sticker has gone
to print. Re‐assess options for clinical secondee
for a potential revised roll‐out plan across re‐
launched care bundles
SEPSIS nurse in place focussed on educating in ED
and MAU.
SEPSIS embedded in mandatory training.
Audits in place of all severe sepsis and septic
shock.
Weekly compliance reports in place and trajectory
improvement plan.
Sepsis 6: Embed sepsis 6 pathway to >90% compliance to
improve outcomes to patients with severe sepsis
The endocrine and neurology consultant posts‐
are out to advert‐ awaiting update . The
substantive business case for additional
respiratory consultant resource is due in Jan 16
(RF) ‐ not complete‐ DMD to review with
Divisional Manager/Directors of Medicine before
end February 2016
Critical Care outreach Service. Review tangible benefits of further expansion‐ the present plan‐ weekdays 12 hours‐
weekends 24/7 For review March ECB
A stepped approach has been agreed ‐the CCOS
will provide a costed plan to provide 24/7 cover
at the weekend initially and the benefit of further
expansion will then be reviewed. Will be
reviewed at March ECB.
Timely 24/7 review of deteriorating patients
Embed appropriate use of Treatment Escalation Plan
(TEP). The Adult TEP is now in place to document
treatment and CPR decisions. Community‐ wide
adoption of TEP is underway with PCH and KCCG.
First Audit of TEP form use completed. In general
documentation/form completion was good apart
from Mental Capacity assessments.
Safeguarding/MCA nurse involved. Paediatric
TEP introduced Jan 16‐ however evidence from
case review suggests that this is not fully
embedded and further work is required.
Consideration needed regarding resource‐ to be
discussed Feb ECB
Expected reduction in cardiac arrest calls
Weekend audit data evidencing patient review has
commenced.
Audit key Care bundles: phase 1 Respiratory
(Pneumonia/COPD)
Audit of Care Bundle pathway ‐ reported to July
ECB
Audit programme to be established to evidence
conformance
14Training/Culture/
Audit31‐Jan‐16
Amanda
Thompson
Roger Langford
Green
15Training/Culture/
Audit31‐Jan‐16 Sally Shipley Green
16 Fractured NoF 31‐Jan‐16 Duncan Bliss Red
17 Fractured NoF 30‐Apr‐16 Claire Rotman Amber 30/04/2016
18 Fractured NoFSue Ingram/
Kathy SmithAmber
19 Fractured NoF 30‐Apr‐16Simon McIntosh/
Helen WilliamsAmber
20 Fractured NoF 30‐Apr‐16 Duncan Bliss Green
21 Fractured NoF 31‐Dec‐15Simon McIntosh/
Ben WarrickRed
22 Fractured NoF 31‐Dec‐15
Sean Dixon/
Laura Wesson/
Helen Williams
Amber
23 Fractured NoF 31‐Dec‐15Helen Williams /
Kevin WrightRed
24 Fractured NoF 29‐Feb‐16 David Smith Green
25 Fractured NoF 31‐Dec‐15 Duncan Bliss Red
26Congestive Cardiac
Failure31‐Jan‐16
Jo Davies, HF
Specialist Nurse
Roberta Fuller,
Interim
Cardiology
Service Lead
Green Complete.
Pathways and
protocols31‐Mar‐16 Barney Scrace Amber
Pathways and
protocols31‐Mar‐16 Frances Keane Amber
Pathways and
protocols31‐Mar‐16 Steve Dickinson Amber
Consider provision of on‐going care for NOF patients to be
within designated orthogeriatric rehabilitation units in the
community. This is not an action!
Aim to roll out the change package following
the same ward list programme as the E‐obs
scheduling but over 30, 60, 90 day timescale.
launch event for the Ward Sisters and Matrons at
the start of each phase so that they are familiar
with the change package.
Engagement of some specialist/non ward based
nurses in helping with the roll out at clinical level.
Improve awareness and management of the
deteriorating patient ‐ Junior Medical staff ‐
Establish/Review Training ‐ ward based simulation. Nursing ‐
proposal required
Reduction of Sis relating to the deteriorating
patient
Data quality and data review ‐ Identification of patients at
risk of deterioration most likely to deteriorate after
admission or on the wards.
2 members of the ECB tasked to review existing
tools for patients being admitted through ED and
MAU. Proposed scoring system agreed and to be
trialled in ED. Sepsis nurse reviewing patients
with NEWS of 5 or more who deteriorate on the
wards
Develop a systematic process to identify the risk
of deterioration / sick patients admitted through
medical take
Redesign the pathway to ensure that patients who require
post‐ operative surgical review are seen by the orthopaedic
consultant.
In place. Any patient escalated have review.
Approved with orthopaedic deep dives with
Medical Director. Job plans being revised
Monitored through PALS/complaints
Encourage and facilitate referral to the heart failure nurse
service:
To existing service by
a) advertising service to other areas, particularly eldercare
and MAU
b) Appointment to 2nd heart failure nurse post
Second HF Nurse taking up post in mid January
2016 . Promotion of the service to other
specialties is underway and will improve with
second HF nurse in post.
Increase in patient referrals to the HF Nurse‐
review.
Review opportunity for a standardised anaesthetic
approach for frail elderly hip fracture patients.
In brief: on‐going consultations re standardizing
anaesthesia for NOF but anaesthetists feel a
good idea ‐ presented an anaesthetic governance
meeting. Under review by anaesthetics
Consistent junior medical ward staff on the Trauma Unit.‐
what does this mean?
Deanery approval for F2s to be under the
Orthogeriatric supervision looking after only
factured hips from Aug 16
Monitored through denary feedback
Improve checking and cross‐referencing of HES data and
NHFD.
Improve documentation of fluid balance and nutrition on
the Trauma Unit.
Documentation reviewed by pre CQC team on
Trauma 17 12 15. Feedback was that there was
no issue with the current documentation and
completion on trauma for their visit. new food
and fluid charts currently being trialled on
Trauma unit and driven by ward managers/senior
nursing staff to good effect. Physicians feel this
has been an improvement
Audit of documentation
Increase orthogeriatric time on Trauma Unit to 15 PAs per
week.
Fascia iliaca nerve blocks to be implemented as standard
part of NOF pathway – to be progressed as part of Listening
into Action review.
NoF Pathway implemented 3 Dec 15
where patients receive clerking and block where
appropriate in ED following x‐ray on arrival
Pathway in place ‐ reviews on‐going
Increase physiotherapy cover for trauma patients to seven
days a week and increase number of patients mobilised on
Day 1.
Additonal physios expected in post April 16
including provision for 7/7 working Reduced length of stay
.
The JD etc for extra orthogeriatrician is being
finalised by Helen Williams. A short term plan is
agreed for the short/immediate term for
orthogeriatric staff grade which is very doable
with good potential candidates and is being
sorted by Laura Wesson/Helen . This would just
be for NOFs and will hopefully be up and running
early next year. Job plan in progress. Full time
Staff grade in orthogeriatrics starting end of
January 16
Increased PAs
Update from Helen Williams
Clerical support for 30 day follow‐up.
Built in to job description for ring and remind
administration team currently being recruited to
the task of 30 day follow‐up. Staff in place by
end Feb 16
NoF best practice pathway measure being met
Re‐launch phase 3 pathway for AKI to improve consistency
and systematic care and improve outcomes Introduced at grand round Dec 15. Further
embedding required Audit programme to be established
Explore potential for the use of advance care pathways and
opportunities for use of the SPICT tool. Assess benefit of
system wide projectEstablish working group with key clinicians Feb
16
New development activity
Triangulate learning from SIs and complaints relating to
mortality
Themes from Sis and mortality review
disseminated through Divisions. Medical
Director has established a clinical quality board
to enable cross division/trust wide learning. First
meeting ‐23 February 2016
Ensure learning achieved and shared across
organisation ‐ Identify and implement any
process change needed
Pathways and
protocols29‐Feb‐16
Duncan Browne/
Kim O Keefe Amber
Identification of in‐patients with diabetes who are at risk of
hyopgylcaemic episodes. Review data for inpatient
diabetics to understand the scope of required actions and
identify leads and timeframes
Report to be submitted to Feb 16 Emergency
care board
Identification of patients at risk of hypoglycaemic
episodes and appropriate action taken